Open AccessIndian contribution toward biomedical research and development in COVID-19: A systematic review
Author(s) -
Hardeep Kaur,
Manpreet Kaur,
Anusuya Bhattacharyya,
Manisha Prajapat,
Prasad Thota,
Phulen Sarma,
Subodh Kumar,
Gurjeet Kaur,
Saurabh Sharma,
Ajay Prakash,
P K Saifuddin,
Bikash Medhi
Publication year - 2021
Publication title -
indian journal of pharmacology/the indian journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.286
H-Index - 59
eISSN - 1998-3751
pISSN - 0253-7613
DOI - 10.4103/ijp.ijp_168_21
Subject(s) - covid-19 , globe , pandemic , alternative medicine , systematic review , public relations , political science , medicine , business , medline , virology , pathology , disease , outbreak , infectious disease (medical specialty) , ophthalmology , law
COVID-19 pandemic led to an unprecedented collaborative effort among industry, academia, regulatory bodies, and governments with huge financial investments. Scientists and researchers from India also left no stone unturned to find therapeutic and preventive measures against COVID-19. Indian pharmaceutical companies are one of the leading manufacturers of vaccine in the world, are utilizing its capacity to its maximum, and are one among the forerunners in vaccine research against COVID-19 across the globe. In this systematic review, the information regarding contribution of Indian scientists toward COVID-19 research has been gathered from various news articles across Google platform apart from searching PubMed, WHO site, COVID-19 vaccine tracker, CTRI, clinicaltrials.gov, and websites of pharmaceutical companies. The article summarizes and highlights the various therapeutic and vaccine candidates, diagnostic kits, treatment agents, and technology being developed and tested by Indian researcher community against COVID-19.